Objective: We investigated the clinical safety and feasibility of an algorithm we developed for the decision-making on neurovascular bundle preservation in radical prostatectomy to decrease the incidence of positive surgical margins. Methods: We prospectively applied our algorithm to 82 patients (164 prostate sides) with clinically localized prostate cancer who underwent radical prostatectomy at our institution between October 2004 and September 2006. The algorithm was developed using the apical core characteristics, clinical T stage, preoperative prostate-specific antigen level and Gleason sum. All prostate sides were divided into two groups by the algorithm: 115 sides (70.1%) were qualified for neurovascular bundle preservation (favorable algorithm side group) and 49 sides (29.9%) for non-neurovascular bundle preservation (unfavorable algorithm side group). Results: Median patient age was 66 years (range: 52 -77) and median prostate-specific antigen was 7.1 ng/ml (range: 1.4 -29.6). Overall, a positive surgical margin was observed in 23 sides (14.0%). The incidence of positive surgical margins at the apex was significantly correlated with the maximal diameter of the tumor in the apex (P , 0.001). The incidence of positive surgical margins was 8.7% in the favorable algorithm group, whereas it was 26.5% in the unfavorable algorithm group (P ¼ 0.003). When this algorithm was combined with surgeons' intraoperative assessments, the incidence of positive surgical margins was 2.1% in neurovascular bundle preservation sides, compared with 25.0% in non-neurovascular bundle preservation sides (P ¼ 0.002). Conclusions: This simple algorithm is safe and feasible for the decision-making on neurovascular bundle preservation from the aspect of cancer control in radical prostatectomy patients.
INTRODUCTION
Nerve-sparing radical prostatectomy (RP) is an important procedure for the recovery of the erectile function after surgery, which leads to the improvement in the quality of life of patients with organ-confined prostate cancer (1) . However, it is still controversial whether this procedure compromises surgical margin (SM) status. The neurovascular bundles (NVBs) are located outside of the prostatic capsule, and positive SMs can occur as a result of either incising into prostate cancer that extends beyond the prostatic capsule or the anterior side of the apex lacking the prostate capsule or incising into an intracapsular cancer via an inadequate procedure (2) . Many studies have indicated that a positive SM is an independent risk factor for disease progression and mortality (2 -4). Therefore, NVBs should be preserved appropriately without compromising SM status, and the decision for NVB preservation should be made carefully.
In this study, we validated an algorithm we developed as a decision-making tool for NVB preservation in RP to confirm its clinical safety and feasibility for SM status.
PATIENTS AND METHOD
Between October 2004 and September 2006, 95 patients with clinically localized prostate cancer underwent RP at our institution. A total of 13 patients (11 with neoadjuvant hormonal treatment and 2 with an insufficient total number of biopsy cores of less than 6) were excluded from the study. Finally, 82 patients were enrolled in this study.
All patients had serum prostate-specific antigen (PSA) determination (ECLusys PSA II assay) before prostate biopsy. Systematic prostate biopsy was performed by taking 14 cores from each of 16 patients in our institution, and a median of 8 (range: 6 -12) biopsy cores in 66 patients who underwent biopsy in other clinics. Clinical stage was determined by digital rectal examination, transrectal ultrasound, abdominal computed tomography, chest X-ray and bone scanning. Magnetic resonance imaging was performed when prostatic capsular penetration was suspected. The preoperative erectile function was evaluated by the International Index of Erectile Function Questionnaire (IIEF5) and the penile circumferential change by nocturnal penile tumescence (5) .
RP was done through a standard retropubic approach with limited pelvic lymph node dissection. The nerve-sparing procedure was performed as described by Walsh (6) . An optical loupe was not routinely used during the operation in the series of this study. Fourteen surgeons and 7 staff members participated in the radical prostatectomies in this academic-institution setting.
The algorithm for the decision-making on NVB preservation consisted of four elements, including the clinical T stage, preoperative PSA, Gleason sum on biopsy and cores in the apex (Fig. 1a and b) . These parameters have been previously reported to predict SM status (2,7 -12) . If 6 -10 biopsy cores incorporating a sextant biopsy and 1 -4 lateral sides were obtained, a core in the apex was defined as a distal core on sextant biopsy (Fig. 1a) . If 12 biopsy cores incorporating a sextant biopsy and 6 lateral sides were obtained, a core in the apex was defined as a distal or lateraldistal core. If apical anterior core biopsy was performed, a positive core in the apex was defined as an apical anterior core in addition to a distal and lateral-distal core. Of all the prostate sides, 32 (19.5%) were in the 6-core pattern, 54 (32.9%) in the 8-core pattern, 44 (26.9%) in the 10-core pattern, 2 (1.2%) in the 12-core and 32 (19.5%) in the 14-core and apical anterior core pattern. The cutoff values for the other parameters were 10 ng/ml for PSA and 7 for the Gleason sum on biopsy.
The algorithm we used in this study is shown in Fig. 1b . In this algorithm, nerve-sparing RP was not offered to patients with T2c because it has been shown to independently predict the likelihood of a positive SM (2, 13) . In patients with T1c, T2a or T2b, the presence of a positive core in the apex was evaluated for each prostate side. If a core in the apex was negative, or positive with a preoperative PSA level of ,10 ng/ml and Gleason sum of 6 or less, the NVB on that side was preserved. The decision-making for NVB preservation was generally done based on this algorithm for all sides. However, in some cases, the NVB was resected due to the patient's preference or surgeons' assessment of cancer biology; for example, a positive core rate on biopsy, or palpable induration or adhesion of the prostate during the operation.
Both biopsy specimens and prostatectomy specimens were histologically examined by several pathologists. All biopsy specimens from other clinics were reviewed by pathologists in our institution. The prostatectomy specimens were horizontally sectioned at 5 mm intervals. In addition, apical specimens were longitudinally sectioned at 5 mm intervals. Stage and histological grade were assigned using the 2002 UICC-American Joint Committee on Cancer TNM system and the Gleason system, respectively. A positive SM was defined as cancer tissue present at the inked specimen edge. Extraprostatic extension (EPE) was defined as cancer extension over the prostatic capsule. If the NVB was preserved, EPE in the NVB was defined as EPE in the posterolateral region of the prostate. A tumor in the apex was defined as a tumor in a 5 mm section of the apex in a prostatectomy specimen, and the maximal diameter of the tumor in the apex as the long diameter of the tumor estimated from all sections of the apex.
All prostate sides were divided into two groups by the algorithm: the favorable algorithm side group qualified for NVB preservation, and the unfavorable algorithm side group for non-NVB preservation. The chi-square test, Fisher's exact test and Mann -Whitney U-test were carried out to compare various clinical and pathological parameters between the groups. A P value of ,0.05 was considered to be statistically significant. We used the computer program StatView 5.0 for Windows (SAS Institute, Cary, NC, USA) for statistical analyses.
RESULTS
The characteristics of patients are shown in Table 1 . Of the 82 patients, bilateral NVB preservation was done for 47 (57.3%), unilateral NVB preservation for 21 (25.6%) and non-NVB preservation for 14 (17.1%) according to our algorithm. Of all the prostates sides, 115 (70.1%) were in the favorable algorithm side group and 49 (29.9%) in the unfavorable algorithm side group.
The incidence of pathologically confirmed organ-confined disease (OCD) was significantly higher in the favorable algorithm side group than in the unfavorable algorithm side group (91.3% vs. 57.1%, respectively, P , 0.001) ( Table 2) .
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Indication for nerve-sparing radical prostatectomy A tumor in the apex was observed in 79 sides (48.2%), including 47 sides of the favorable algorithm side group and 32 sides of the unfavorable algorithm side group. The median maximal diameter of the tumor in the apex was 5.0 mm (range: 1.0 -17.0) in the favorable algorithm side group compared with 7.0 mm (range: 2.0 -20.0) in the unfavorable algorithm side group (P ¼ 0.019). Overall, positive SMs were observed in 23 sides (14.0%), with 11 sides at the apex. The rate was 6.0% in sides with pathologically confirmed OCD, but increased to 48.4% in those with non-OCD (P , 0.001). The incidence of positive SMs at the apex was correlated with the maximal diameter of the tumor in the apex (Fig. 2) . The overall incidence of positive SMs was significantly lower in the favorable algorithm side group than in the unfavorable algorithm side group (8.7% vs. 26.5%, P ¼ 0.003) ( Table 3 ). In the favorable algorithm side group, 48 sides (41.7%) actually had NVB preservation, and 32 sides (27.8%) had non-NVB preservation based on the surgeons' assessments of biological risk. In these 32 sides, the positive core rate was significantly higher than that of the other sides in the favorable algorithm side group (median: 0% vs. 31.0%, P , 0.001). When this algorithm was combined with the surgeons' assessments, a positive SM and EPE were observed in one side (2.1%) and zero in NVB-preservation sides, compared with eight (25.0%) and four (12.5%) non-NVB preservation sides, respectively (P ¼ 0.002, P ¼ 0.022). Neither a positive SM nor EPE in NVB was observed in NVB sides preserved according to the algorithm.
DISCUSSION
NVB preservation is mandatory to maintain the erectile function of patients with RP (1). The rate of recovery of the postoperative erectile function, although depending on age, is Figure 1 . (a) Schematic drawing of a 6 -14 core (circles and triangle) biopsy site on the posterior surface of the unilateral prostate. A core in the apex is drawn as a black circle or black triangle. If 6 -10 biopsy cores (A and B) incorporating sextant biopsy and 1 -4 lateral sides were obtained, a core in the apex was defined as a distal core on sextant biopsy. If 12 biopsy cores (C) incorporating a sextant biopsy and 6 lateral sides were obtained, a core in the apex was defined as a distal and lateral-distal core. If apical anterior core biopsy (D) was performed with 14 biopsy cores, a core in the apex was defined as an apical anterior core (black triangle) in addition to a distal and lateral-distal core. (b) The algorithm for the decision-making on neurovascular bundle (NVB) preservation. First, the clinical stage was determined by digital rectal examination (DRE). If the clinical stage was T2c, bilateral NVB were not preserved. Next, the presence of a positive core in the apex was evaluated in each prostate side. If cores in the apex were negative, ipsilateral NVB were preserved. If a core in the apex was positive with a PSA level of ,10 ng/ml and a Gleason sum of 6 or less, ipsilateral NVB were preserved.
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higher in patients with bilateral NVB preservation than in those with unilateral preservation (14) . Our previous study revealed that the efficacy of phosphodiesterase type 5 inhibitors also depended on NVB preservation (15) . A recent study suggested that bilateral NVB preservation could also contribute to early recovery of urinary continence after RP (16) . Therefore, it is important to increase the number of candidates for nerve-sparing RP with respect to quality of life, as long as it does not compromise SM status. Who is an ideal candidate for nerve-sparing RP? The criteria to select candidates may require decreasing the incidence of positive SMs and increasing the proportion of NVBs preserved (9). The incidence of positive SMs has been reported to range from 2.5% to 34% in nerve-sparing RP based on various criteria (7 -10,17,18) . Several preoperative parameters, including the clinical T stage, PSA value, Gleason sum, number of positive biopsy cores and tumor length of a single core, are thought to be factors that affect the SM status (2,7,9 -12). The incidence of positive SMs is known increase depending on the tumor extension (2,7 -11) . Several studies have shown that EPE commonly occurs in the posterolateral region near the NVB (2, 10) . This indicates that the majority of cancer with EPE is likely to have a risk of a positive SM with the nerve-sparing procedure. Walsh (17) reported that it was possible to preserve NVBs in all patients with OCD without compromising SM status. Therefore, the selection criteria for NVB preservation need to predict OCD by using preoperative factors that affect SM status. Moreover, this assessment should be performed for each prostate side separately in order to maximize the proportion of NVBs preserved (9 -11) .
However, it is notable that positive SMs occur in 2.5 -27% of cases despite the presence of OCD (7 -11,17) . The apex, which lacks the prostate capsule, is the most common site of positive SMs (2, 4, 7, 8) . The present study revealed that the maximal diameter of a tumor in the apex was related to the incidence of positive SMs at the apex. The short length of the inferior pedicle allows a tumor in the apex to spread more easily into the perineural spaces (2). These findings suggested that predicting the extension of a tumor in the Gleason sum on biopsy (%) apex could contribute to decreasing the incidence of positive SMs in nerve-sparing RP. Moreover, it was reported that careful excision at the apex could improve the recovery of the erectile function (19) . Therefore, evaluation of the tumor extension in the apex may be important for the decisionmaking on NVB preservation. We developed an algorithm that aimed to decrease the incidence of positive SMs by predicting OCD and tumor extension in the apex for each prostate side. This is a simple algorithm mainly based on biopsy core features in the apex. Of all sides, 115 (70.1%) were qualified for NVB preservation according to the algorithm. The present study also confirmed that our algorithm could predict OCD and tumor extension in the apex. As a result, the incidence of positive SMs was only 2.1% when NVBs were preserved according to the algorithm. Similar to our results, several studies have shown that algorithms using risk factors for positive SMs decrease the incidence of positive SMs and increase the proportion of NVBs preserved (9,10). Shah et al. (9) developed an algorithm based on the Gleason score, percent tumor volume and perineural invasion in the biopsy specimen. Of 526 sides with clinically localized prostate cancer, 483 sides (91.8%) were qualified for NVB preservation. The incidence of positive SMs was 4.6%. Likewise, Kamat et al. (10) reported an algorithm including tumor length in the biopsy core and the location of positive cores. Their algorithm led to NVB preservation in 502 (93.3%) of 538 sides with clinically localized prostate cancer, which resulted in decreasing the incidence of positive SMs (2.5%).
In the present study, at 32 sides of the favorable algorithm side group NVBs were resected based on the surgeons' assessments contrary to the algorithm. This was associated with the positive core rate. These sides had a high incidence of positive SMs similar to that of the unfavorable algorithm side group. In addition, three sides (9.4%) had EPE in NVBs, implying a risk of positive SMs (12) . If NVB were preserved in these sides, there might likely be an increase in the incidence of positive SMs. Thus, intraoperative assessment of EPE by surgeons should not be ignored in the decision-making on NVB preservation, as reported by Walsh (17) . Our algorithm and the surgeons' assessments led to prevention of an increase in positive SMs in the nervesparing procedure. We propose that this algorithm and the surgeons' intraoperative assessments are equally important to prevent positive SMs.
We prospectively investigated the usefulness of the algorithm for the decision-making on NVB preservation before RP. However, the present study had some limitations. The total number of biopsy cores and the locations of biopsy cores varied because the majority of patients underwent prostate biopsy in other clinics. In our academic training-institution setting, multiple surgeons and pathologists were involved. The proportion of NVBs qualified for preservation was lower with our algorithm than with others. In addition, only 48 (41.7%) of all sides in the favorable algorithm side group actually had NVB preservation. However, the present algorithm was simple and safe from the aspect of cancer control. Furthermore, it became a more powerful tool when combined with surgeons' assessments. In a future study, we need to investigate other aspects of the usefulness of this algorithm such as the postoperative erectile function and prognosis.
CONCLUSIONS
We developed a simple algorithm for decision-making on NVB preservation based on the apical core characteristics, clinical T stage, preoperative PSA level and Gleason sum. NVB preservation was achieved without affecting SM status by using this algorithm. This algorithm is safe and feasible for decision-making on NVB preservation from the aspect of cancer-control in RP patients. Jpn J Clin Oncol 2010;40(4) 347
